BeiGene | The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

⟵ Back to Search Results

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Beigene Study ID

BGB-283-CN-001

ClinicalTrials.gov ID

NCT03641586

China Drug Trials ID

CTR20150575

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Sex: All

Age: 18 Years / 75 Years

No Study Documents